Balance and Mobility Performance Along the Alzheimer's Disease Spectrum

被引:24
|
作者
Yoon, Bora [1 ]
Choi, Seong Hye [2 ]
Jeong, Jee Hyang [3 ]
Park, Kyung Won [4 ]
Kim, Eun-Joo [5 ,6 ]
Hwang, Jihye [7 ]
Jang, Jae-Won [8 ]
Kim, Hee Jin [9 ]
Hong, Jin Yong [10 ,11 ]
Lee, Jong-Min [11 ]
Kang, Ju-Hee [12 ]
Yoon, Soo Jin [13 ]
机构
[1] Konyang Univ, Coll Med, Dept Neurol, Daejeon, South Korea
[2] Inha Univ, Dept Neurol, Sch Med, Incheon, South Korea
[3] Ewha Womans Univ, Dept Neurol, Sch Med, Seoul, South Korea
[4] Dong A Univ, Coll Med, Dong A Med Ctr, Dept Neurol, Busan, South Korea
[5] Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, Busan, South Korea
[6] Med Res Inst, Busan, South Korea
[7] Keimyung Univ, Dept Neurol, Dongsan Med Ctr, Daegu, South Korea
[8] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Neurol, Coll Med, Chunchon, South Korea
[9] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea
[10] Yonsei Univ, Dept Neurol, Wonju Coll Med, Wonju, South Korea
[11] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea
[12] Inha Univ, Dept Pharmacol, Sch Med, Incheon, South Korea
[13] Eulji Univ, Eulji Univ Hosp, Dept Neurol, Sch Med, Daejeon 35233, South Korea
基金
新加坡国家研究基金会;
关键词
Alzheimer's disease; apolipoprotein E; cognition; female; postural balance; subjective cognitive decline; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; AMYLOID DEPOSITION; NATIONAL INSTITUTE; ASSESSMENT BATTERY; HEALTHY-ADULTS; KOREAN VERSION; GO TEST; DECLINE;
D O I
10.3233/JAD-190601
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Balance impairments are common in patients with Alzheimer's disease (AD) dementia. Objective: We sought to determine the stage along the AD spectrum during which balance impairments appear and identify factors associated with a decline in balance function. Methods: Our cross-sectional study included 295 participants; 71 were cognitively normal (CN), 96 reported subjective cognitive decline (SCD), 72 had amnestic mild cognitive impairment (MCI), and 56 had AD dementia. The balance and mobility function was assessed using the Timed Up and Go test (TUG) and the One-Leg Standing Test (OLST). Results: Participants in the MCI and AD dementia groups were older than those in the cognitively normal and SCD groups. TUG and OLST test scores were linearly correlated with Mini-Mental Status Examination-Korean Version score (MMSE-KC). TUG score increased with greater AD spectrum severity (all p < 0.001), whereas OLST score showed a precipitous impairment starting in the SCD group (all p <0.001), even after adjusting for age, sex, MMSE-KC, Geriatric depression scale, and body mass index. Based on subgroup analyses, in females and apolipoprotein E (APOE) epsilon 4 carriers, there was significant balance/mobility impairment in the SCD group when compared to the CN group. Conclusion: Our results suggest that balance/mobility is related to cognitive function and that balance/mobility impairment can be observed beginning in the SCD stage. Furthermore, CN females and APOE epsilon 4 carriers had better balance and mobility when compared to females and APOE epsilon 4 carriers along the ADD spectrum/with cognitive impairment respectively.
引用
收藏
页码:633 / 644
页数:12
相关论文
共 50 条
  • [1] Cholinergic white matter pathways along the Alzheimer's disease continuum
    Nemy, Milan
    Dyrba, Martin
    Brosseron, Frederic
    Buerger, Katharina
    Dechent, Peter
    Dobisch, Laura
    Ewers, Michael
    Fliessbach, Klaus
    Glanz, Wenzel
    Goerss, Doreen
    Heneka, Michael T.
    Hetzer, Stefan
    Incesoy, Enise I.
    Janowitz, Daniel
    Kilimann, Ingo
    Laske, Christoph
    Maier, Franziska
    Munk, Matthias H.
    Perneczky, Robert
    Peters, Oliver
    Preis, Lukas
    Priller, Josef
    Rauchmann, Boris-Stephan
    Roeske, Sandra
    Roy, Nina
    Scheffler, Klaus
    Schneider, Anja
    Schott, Bjorn H.
    Spottke, Annika
    Spruth, Eike J.
    Wagner, Michael
    Wiltfang, Jens
    Yakupov, Renat
    Eriksdotter, Maria
    Westman, Eric
    Stepankova, Olga
    Vyslouzilova, Lenka
    Duezel, Emrah
    Jessen, Frank
    Teipel, Stefan J.
    Ferreira, Daniel
    BRAIN, 2023, 146 (05) : 2075 - 2088
  • [2] Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia
    Giacomucci, Giulia
    Moschini, Valentina
    Piazzesi, Diletta
    Padiglioni, Sonia
    Caruso, Cecilia
    Nuti, Claudia
    Munarin, Alice
    Mazzeo, Salvatore
    Galdo, Giulia
    Polito, Cristina
    Emiliani, Filippo
    Frigerio, Daniele
    Morinelli, Carmen
    Bagnoli, Silvia
    Ingannato, Assunta
    Nacmias, Benedetta
    Sorbi, Sandro
    Berti, Valentina
    Bessi, Valentina
    CORTEX, 2024, 172 : 125 - 140
  • [3] Mind's eye in the Alzheimer's disease spectrum continuum
    Gabrielli, Giulia Bechi
    D'Antonio, Fabrizia
    Di Vita, Antonella
    Margiotta, Roberta
    Panigutti, Massimiliano
    Boccia, Maddalena
    Piccardi, Laura
    Palermo, Liana
    Salati, Emanuela
    Sepe Monti, Micaela
    Talarico, Giuseppina
    Bruno, Giuseppe
    Guariglia, Cecilia
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 103 (01) : 194 - 207
  • [4] Detecting At-Risk Alzheimer's Disease Cases
    Fladby, Tormod
    Palhaugen, Lene
    Selnes, Per
    Waterloo, Knut
    Brathen, Geir
    Hessen, Erik
    Almdahl, Ina Selseth
    Arntzen, Kjell-Arne
    Auning, Eirik
    Eliassen, Carl Fredrik
    Espenes, Ragna
    Grambaite, Ramune
    Grontvedt, Goril Rolfseng
    Johansen, Krisztina Kunszt
    Johnsen, Stein Harald
    Kalheim, Lisa Flem
    Kirsebom, Bjorn-Eivind
    Muller, Kai Ivar
    Nakling, Arne Exner
    Rongve, Arvid
    Sando, Sigrid Botne
    Siafarikas, Nikias
    Stav, Ane Lovli
    Tecelao, Sandra
    Timon, Santiago
    Bekkelund, Svein Ivar
    Aarsland, Dag
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (01) : 97 - 105
  • [5] On the path to 2025: understanding the Alzheimer's disease continuum
    Aisen, Paul S.
    Cummings, Jeffrey
    Jack, Clifford R., Jr.
    Morris, John C.
    Sperling, Reisa
    Froelich, Lutz
    Jones, Roy W.
    Dowsett, Sherie A.
    Matthews, Brandy R.
    Raskin, Joel
    Scheltens, Philip
    Dubois, Bruno
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [6] Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease
    Ho, Jean K.
    Nation, Daniel A.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2018, 24 (07) : 693 - 702
  • [7] Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum
    Herdick, Meret
    Dyrba, Martin
    Fritz, Hans-Christian J.
    Altenstein, Slawek
    Ballarini, Tommaso
    Brosseron, Frederic
    Buerger, Katharina
    Cetindag, Arda Can
    Dechent, Peter
    Dobisch, Laura
    Duezel, Emrah
    Ertl-Wagner, Birgit
    Fliessbach, Klaus
    Freiesleben, Silka Dawn
    Frommann, Ingo
    Glanz, Wenzel
    Haynes, John Dylan
    Heneka, Michael T.
    Janowitz, Daniel
    Kilimann, Ingo
    Laske, Christoph
    Metzger, Coraline D.
    Munk, Matthias H.
    Peters, Oliver
    Priller, Josef
    Roy, Nina
    Scheffler, Klaus
    Schneider, Anja
    Spottke, Annika
    Spruth, Eike Jakob
    Tscheuschler, Maike
    Vukovich, Ruth
    Wiltfang, Jens
    Jessen, Frank
    Teipel, Stefan
    Grothe, Michel J.
    NEUROIMAGE-CLINICAL, 2020, 28
  • [8] Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment
    Sandau, Ursula S.
    Wiedrick, Jack T.
    Smith, Sierra J.
    McFarland, Trevor J.
    Lusardi, Theresa A.
    Lind, Babett
    Harrington, Christina A.
    Lapidus, Jodi A.
    Galasko, Douglas R.
    Quinn, Joseph F.
    Saugstad, Julie A.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 245 - 263
  • [9] Regional brain stiffness changes across the Alzheimer's disease spectrum
    Murphy, Matthew C.
    Jones, David T.
    Jack, Clifford R., Jr.
    Glaser, Kevin J.
    Senjem, Matthew L.
    Manduca, Armando
    Felmlee, Joel P.
    Carter, Rickey E.
    Ehman, Richard L.
    Huston, John, III
    NEUROIMAGE-CLINICAL, 2016, 10 : 283 - 290
  • [10] Attitudes toward clinical trials across the Alzheimer's disease spectrum
    Nuno, Michelle M.
    Gillen, Daniel L.
    Dosanjh, Kulwant K.
    Brook, Jenny
    Elashoff, David
    Ringman, John M.
    Grill, Joshua D.
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9